| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
| DM Dipen Mehta Invst LLC | 67,691 | $677,136.78 | $556,420.02 | -$120,716.76 | -17.83% |
| ARCA Exchange | US Country |
The company described appears to focus on investments in the healthcare technology sector, encompassing both U.S. and international markets. It commits at least 80% of its net assets, along with any borrowings for investment purposes, towards equity securities listed on U.S. and foreign exchanges that are related to healthcare technology. These can include stocks of any market capitalization, as well as American Depository Receipts (ADRs) of such securities, allowing for broader exposure to global healthcare innovation. The fund's approach is non-diversified, indicating a concentrated investment strategy in the healthcare technology arena.
This service focuses on investing in exchange-listed equity securities from the healthcare technology sector. The investments can be in companies of any size, from small startups to large corporations, provided they operate within the healthcare technology space. The aim here is to capitalize on the growth potential of innovative healthcare solutions and technologies.
Another offering involves investing in ADRs, which are a type of equity security that represents shares in a foreign company available for purchase on American exchanges. This allows the fund to gain exposure to international healthcare technology companies without the complexities of investing directly in foreign markets. ADR investments can offer diversification beyond the U.S. healthcare technology sector, tapping into global innovation and growth opportunities.